{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T05:19:59Z","timestamp":1794892799904,"version":"4.9.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T00:00:00Z","timestamp":1736899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute of Drug Abuse","doi-asserted-by":"crossref","award":["R01DA048876"],"award-info":[{"award-number":["R01DA048876"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"DOI":"10.1186\/s12954-025-01155-6","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:00:22Z","timestamp":1737111622000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["An exploration of desired abstinent and non-abstinent recovery outcomes among people who use methamphetamine"],"prefix":"10.1186","volume":"22","author":[{"given":"Alex","family":"Elswick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Fallin-Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Roper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan","family":"Batty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"McLouth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Stoops","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary L.","family":"Surratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie B.","family":"Oser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,15]]},"reference":[{"issue":"12","key":"1155_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","volume":"78","author":"B Han","year":"2021","unstructured":"Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults. JAMA Psychiatry. 2021;78(12):1329\u201342.","journal-title":"JAMA Psychiatry"},{"key":"1155_CR2","doi-asserted-by":"crossref","unstructured":"Kariisa M, Seth P, Scholl L, Wilson N, Davis NL. Drug overdose deaths involving cocaine and psychostimulants with abuse potential among racial and ethnic groups\u2013United States, 2004\u20132019. Drug and alcohol dependence. 2021;227:109001.","DOI":"10.1016\/j.drugalcdep.2021.109001"},{"key":"1155_CR3","doi-asserted-by":"publisher","first-page":"805002","DOI":"10.3389\/fpsyt.2021.805002","volume":"12","author":"JR Havens","year":"2022","unstructured":"Havens JR, Knudsen HK, Strickland JC, Young AM, Babalonis S, Lofwall MR, Walsh SL. Recent increase in methamphetamine use in a cohort of rural people who use drugs: further evidence for the emergence of twin epidemics. Front Psychiatry. 2022;12:805002.","journal-title":"Front Psychiatry"},{"key":"1155_CR4","volume-title":"National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","year":"2022","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey on Drug Use and Health. Rockville, MD: Center for Behavioral Health Statistics and Quality; 2022."},{"issue":"2","key":"1155_CR5","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/jrh.12388","volume":"36","author":"HL Surratt","year":"2020","unstructured":"Surratt HL, Otachi JK, Williams T, Gulley J, Lockard AS, Rains R. Motivation to change and treatment participation among syringe service program utilizers in rural Kentucky. J Rural Health. 2020;36(2):224\u201333.","journal-title":"J Rural Health"},{"issue":"8","key":"1155_CR6","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1111\/add.15329","volume":"116","author":"J Henssler","year":"2021","unstructured":"Henssler J, M\u00fcller M, Carreira H, Bschor T, Heinz A, Baethge C. Controlled drinking\u2014non-abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta\u2010analysis and meta\u2010regression. Addiction. 2021;116(8):1973\u201387.","journal-title":"Addiction"},{"key":"1155_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jsat.2018.02.004","volume":"88","author":"SE Zemore","year":"2018","unstructured":"Zemore SE, Lui C, Mericle A, Hemberg J, Kaskutas LA. A longitudinal study of the comparative efficacy of women for Sobriety, LifeRing, SMART Recovery, and 12-step groups for those with AUD. J Subst Abuse Treat. 2018;88:18\u201326.","journal-title":"J Subst Abuse Treat"},{"key":"1155_CR8","unstructured":"Van Wormer K, Davis DR. Addiction treatment: A strengths perspective. Belmont, CA. 2008."},{"key":"1155_CR9","first-page":"117822182211038","volume":"16","author":"J Dickson-Gomez","year":"2022","unstructured":"Dickson-Gomez J, Spector A, Weeks M, Galletly C, McDonald M, Green Montaque HD. You\u2019re not supposed to be on it forever: medications to treat opioid use disorder (MOUD) related stigma among drug treatment providers and people who use opioids. Subst Abuse: Res Treat. 2022;16:11782218221103859.","journal-title":"Subst Abuse: Res Treat"},{"key":"1155_CR10","doi-asserted-by":"publisher","first-page":"100036","DOI":"10.1016\/j.dadr.2022.100036","volume":"2","author":"HT Padovano","year":"2022","unstructured":"Padovano HT, Levak S, Vadhan NP, Kuerbis A, Morgenstern J. The role of daily goal setting among individuals with alcohol use disorder. Drug Alcohol Depend Rep. 2022;2:100036.","journal-title":"Drug Alcohol Depend Rep"},{"key":"1155_CR11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.addbeh.2014.10.036","volume":"42","author":"JL Enggasser","year":"2015","unstructured":"Enggasser JL, Hermos JA, Rubin A, Lachowicz M, Rybin D, Brief DJ, Roy M, Helmuth E, Rosenbloom D, Keane TM. Drinking goal choice and outcomes in a web-based alcohol intervention: results from VetChange. Addict Behav. 2015;42:63\u20138.","journal-title":"Addict Behav"},{"issue":"2","key":"1155_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1176\/appi.ajp.2019.19121284","volume":"177","author":"ND Volkow","year":"2020","unstructured":"Volkow ND. Personalizing the treatment of substance use disorders. Am J Psychiatry. 2020;177(2):113\u20136.","journal-title":"Am J Psychiatry"},{"key":"1155_CR13","unstructured":"Food and Drug Administration. (2023). Stimulant use disorders: Developing drugs for treatment. Available at: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/stimulant-use-disorders-developing-drugs-treatment"},{"issue":"3","key":"1155_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1080\/02650533.2022.2034768","volume":"37","author":"Y Xin","year":"2023","unstructured":"Xin Y, Espa\u00f1a M, Davis AK. The acceptability of non-abstinent treatment goals among clinical social workers in the United States. J Social work Pract. 2023;37(3):339\u201354.","journal-title":"J Social work Pract"},{"key":"1155_CR15","doi-asserted-by":"publisher","first-page":"102110","DOI":"10.1016\/j.cpr.2021.102110","volume":"91","author":"CE Paquette","year":"2022","unstructured":"Paquette CE, Daughters SB, Witkiewitz K. Expanding the continuum of substance use disorder treatment: nonabstinence approaches. Clin Psychol Rev. 2022;91:102110.","journal-title":"Clin Psychol Rev"},{"issue":"4","key":"1155_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.15288\/jsad.2020.81.405","volume":"81","author":"H Rosenberg","year":"2020","unstructured":"Rosenberg H, Grant J, Davis AK. Acceptance of non-abstinence as an outcome goal for individuals diagnosed with substance use disorders: a narrative review of published research. J Stud Alcohol Drug. 2020;81(4):405\u201315.","journal-title":"J Stud Alcohol Drug"},{"key":"1155_CR17","first-page":"117822182311993","volume":"17","author":"SE Zemore","year":"2023","unstructured":"Zemore SE, Ziemer KL, Gilbert PA, Karno MP, Kaskutas LA. Understanding the Shared meaning of Recovery from Substance Use disorders: New findings from the what is Recovery? Study. Subst Abuse: Res Treat. 2023;17:11782218231199372.","journal-title":"Subst Abuse: Res Treat"},{"issue":"3","key":"1155_CR18","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jsat.2007.04.014","volume":"33","author":"AB Laudet","year":"2007","unstructured":"Laudet AB. What does recovery mean to you? Lessons from the recovery experience for research and practice. J Subst Abuse Treat. 2007;33(3):243\u201356.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"1155_CR19","doi-asserted-by":"publisher","first-page":"e066068","DOI":"10.1136\/bmjopen-2022-066068","volume":"13","author":"CB Oser","year":"2023","unstructured":"Oser CB, Batty E, Booty M, Eddens K, Knudsen HK, Perry B, Rockett M, Staton M. Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the geographic variation in addiction treatment experiences (GATE) longitudinal cohort study protocol. BMJ open. 2023;13(3):e066068.","journal-title":"BMJ open"},{"key":"1155_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jsat.2017.08.006","volume":"82","author":"AK Davis","year":"2017","unstructured":"Davis AK, Rosenberg H, Rosansky JA. American counselors\u2019 acceptance of non-abstinence outcome goals for clients diagnosed with co-occurring substance use and other psychiatric disorders. J Subst Abuse Treat. 2017;82:29\u201333.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"1155_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1080\/08897077.2015.1015702","volume":"37","author":"AK Davis","year":"2016","unstructured":"Davis AK, Lauritsen KJ. Acceptability of non-abstinence goals among students enrolled in addiction studies programs across the United States. Substance Abuse. 2016;37(1):204\u20138.","journal-title":"Substance Abuse"},{"issue":"9","key":"1155_CR22","doi-asserted-by":"publisher","first-page":"683","DOI":"10.3109\/10826084.2013.782045","volume":"48","author":"L Maffina","year":"2013","unstructured":"Maffina L, Deane FP, Lyons GC, Crowe TP, Kelly PJ. Relative importance of abstinence in clients\u2019 and clinicians\u2019 perspectives of recovery from drug and alcohol abuse. Subst Use Misuse. 2013;48(9):683\u201390.","journal-title":"Subst Use Misuse"},{"issue":"5","key":"1155_CR23","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/add.16409","volume":"119","author":"M Amin-Esmaeili","year":"2024","unstructured":"Amin-Esmaeili M, Farokhnia M, Susukida R, Leggio L, Johnson RM, Crum RM, Mojtabai R. Reduced drug use as an alternative valid outcome in individuals with stimulant use disorders: findings from 13 multisite randomized clinical trials. Addiction. 2024;119(5):833\u201343.","journal-title":"Addiction"},{"issue":"6","key":"1155_CR24","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3109\/10826084.2013.841244","volume":"49","author":"JC Maxwell","year":"2014","unstructured":"Maxwell JC. A new survey of methamphetamine users in treatment: who they are, why they like meth, and why they need additional services. Subst Use Misuse. 2014;49(6):639\u201344.","journal-title":"Subst Use Misuse"},{"key":"1155_CR25","doi-asserted-by":"crossref","unstructured":"Eddie D, Bergman BG, Hoffman LA, Kelly JF. Abstinence versus moderation recovery pathways following resolution of a substance use problem: prevalence, predictors, and relationship to psychosocial well-being in a US national sample. Alcoholism: Clinical and Experimental Research. 2022;46(2):312\u2009\u2013\u200925.","DOI":"10.1111\/acer.14765"},{"issue":"11","key":"1155_CR26","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1111\/j.1360-0443.2006.01609.x","volume":"101","author":"BE Lozano","year":"2006","unstructured":"Lozano BE, Stephens RS, Roffman RA. Abstinence and moderate use goals in the treatment of marijuana dependence. Addiction. 2006;101(11):1589\u201397.","journal-title":"Addiction"},{"key":"1155_CR27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jsat.2018.07.012","volume":"93","author":"SE McCabe","year":"2018","unstructured":"McCabe SE, West BT, Strobbe S, Boyd CJ. Persistence\/recurrence of and remission from DSM-5 substance use disorders in the United States: substance-specific and substance-aggregated correlates. J Subst Abuse Treat. 2018;93:38\u201348.","journal-title":"J Subst Abuse Treat"},{"issue":"6","key":"1155_CR28","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/add.14159","volume":"113","author":"C Rafful","year":"2018","unstructured":"Rafful C, Orozco R, Rangel G, Davidson P, Werb D, Beletsky L, Strathdee SA. Increased non-fatal overdose risk associated with involuntary drug treatment in a longitudinal study with people who inject drugs. Addiction. 2018;113(6):1056\u201363.","journal-title":"Addiction"},{"issue":"7396","key":"1155_CR29","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","volume":"326","author":"J Strang","year":"2003","unstructured":"Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, Gossop M. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326(7396):959\u201360.","journal-title":"BMJ"},{"key":"1155_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.drugpo.2018.02.006","volume":"55","author":"D Showalter","year":"2018","unstructured":"Showalter D. Federal funding for syringe exchange in the US: explaining a long-term policy failure. Int J Drug Policy. 2018;55:95\u2013104.","journal-title":"Int J Drug Policy"},{"key":"1155_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0276-0","volume":"16","author":"JE Goldman","year":"2019","unstructured":"Goldman JE, Waye KM, Periera KA, Krieger MS, Yedinak JL, Marshall BD. Perspectives on rapid fentanyl test strips as a harm reduction practice among young adults who use drugs: a qualitative study. Harm Reduct J. 2019;16:1\u20131.","journal-title":"Harm Reduct J"},{"key":"1155_CR32","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2018.08.007","volume":"63","author":"NC Peiper","year":"2019","unstructured":"Peiper NC, Clarke SD, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122\u20138.","journal-title":"Int J Drug Policy"},{"key":"1155_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-017-0157-y","volume":"14","author":"E Nadelmann","year":"2017","unstructured":"Nadelmann E, LaSalle L. Two steps forward, one step back: current harm reduction policy and politics in the United States. Harm Reduct J. 2017;14:1\u20137.","journal-title":"Harm Reduct J"},{"key":"1155_CR34","doi-asserted-by":"crossref","unstructured":"Ellis JD, Dunn KE, Huhn AS. Harm reduction for opioid use disorder: strategies and outcome metrics. Am J Psychiatry. 2024 May 6.","DOI":"10.1176\/appi.ajp.20230918"},{"key":"1155_CR35","unstructured":"Substance Abuse and Mental Health Services Administration. 2012. Working definition of recovery. Available at: https:\/\/store.samhsa.gov\/sites\/default\/files\/pep12-recdef.pdf"},{"issue":"2","key":"1155_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/npp.2012.179","volume":"38","author":"AC Dean","year":"2013","unstructured":"Dean AC, Groman SM, Morales AM, London ED. An evaluation of the evidence that methamphetamine abuse causes cognitive decline in humans. Neuropsychopharmacology. 2013;38(2):259\u201374. https:\/\/doi.org\/10.1038\/npp.2012.179.","journal-title":"Neuropsychopharmacology"},{"key":"1155_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/bs.irn.2015.02.004","volume":"120","author":"J Harro","year":"2015","unstructured":"Harro J. Neuropsychiatric adverse effects of amphetamine and methamphetamine. Int Rev Neurobiol. 2015;120:179\u2013204.","journal-title":"Int Rev Neurobiol"},{"issue":"9","key":"1155_CR38","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","volume":"39","author":"CG Kevil","year":"2019","unstructured":"Kevil CG, Goeders NE, Woolard MD. Methamphetamine use and cardiovascular disease. Arterioscler Thromb Vascular Biology. 2019;39(9):1739\u201346. https:\/\/doi.org\/10.1161\/ATVBAHA.119.312461.","journal-title":"Arterioscler Thromb Vascular Biology"},{"issue":"3","key":"1155_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/jpet.121.000767","volume":"379","author":"DR Miller","year":"2021","unstructured":"Miller DR, Bu M, Gopinath A, Martinez LR, Khoshbouei H. Methamphetamine Dysregulation of the Central Nervous System and Peripheral immunity. J Pharmacol Exp Ther. 2021;379(3):372\u201385. https:\/\/doi.org\/10.1124\/jpet.121.000767.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"1155_CR40","doi-asserted-by":"publisher","first-page":"zsab001","DOI":"10.1093\/sleep\/zsab001","volume":"44","author":"M Vrajova","year":"2021","unstructured":"Vrajova M, Slamberova R, Hoschl C, Ovsepian S. Methamphetamine and sleep impairments: neurobevaioral correlates and molecular mechanisms. Sleep. 2021;44(6):zsab001. https:\/\/doi.org\/10.1093\/sleep\/zsab001.","journal-title":"Sleep"},{"key":"1155_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jsat.2019.06.009","volume":"104","author":"AA Klein","year":"2019","unstructured":"Klein AA, Seppala MD. Medication-assisted treatment for opioid use disorder within a 12-step based treatment center: feasibility and initial results. J Subst Abuse Treat. 2019;104:51\u201363. https:\/\/doi.org\/10.1016\/j.jsat.2019.06.009.","journal-title":"J Subst Abuse Treat"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01155-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12954-025-01155-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-025-01155-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:00:29Z","timestamp":1737111629000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-025-01155-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,15]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1155"],"URL":"https:\/\/doi.org\/10.1186\/s12954-025-01155-6","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,15]]},"assertion":[{"value":"5 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7"}}